134 related articles for article (PubMed ID: 36717446)
21. Suppression of AMD-Like Pathology by Mitochondria-Targeted Antioxidant SkQ1 Is Associated with a Decrease in the Accumulation of Amyloid β and in mTOR Activity.
Muraleva NA; Kozhevnikova OS; Fursova AZ; Kolosova NG
Antioxidants (Basel); 2019 Jun; 8(6):. PubMed ID: 31208023
[TBL] [Abstract][Full Text] [Related]
22. Autophagy as a Target for the Retinoprotective Effects of the Mitochondria-Targeted Antioxidant SkQ1.
Telegina DV; Kozhevnikova OS; Fursova AZ; Kolosova NG
Biochemistry (Mosc); 2020 Dec; 85(12):1640-1649. PubMed ID: 33705301
[TBL] [Abstract][Full Text] [Related]
23. The mitochondria-targeted antioxidant SkQ1 but not N-acetylcysteine reverses aging-related biomarkers in rats.
Kolosova NG; Stefanova NA; Muraleva NA; Skulachev VP
Aging (Albany NY); 2012 Oct; 4(10):686-94. PubMed ID: 23104863
[TBL] [Abstract][Full Text] [Related]
24. Senescence-accelerated OXYS rats: a model of age-related cognitive decline with relevance to abnormalities in Alzheimer disease.
Stefanova NA; Kozhevnikova OS; Vitovtov AO; Maksimova KY; Logvinov SV; Rudnitskaya EA; Korbolina EE; Muraleva NA; Kolosova NG
Cell Cycle; 2014; 13(6):898-909. PubMed ID: 24552807
[TBL] [Abstract][Full Text] [Related]
25. What is "phenoptosis" and how to fight it?
Skulachev VP
Biochemistry (Mosc); 2012 Jul; 77(7):689-706. PubMed ID: 22817532
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial Dysfunction as a Predictor and Driver of Alzheimer's Disease-Like Pathology in OXYS Rats.
Tyumentsev MA; Stefanova NA; Muraleva NA; Rumyantseva YV; Kiseleva E; Vavilin VA; Kolosova NG
J Alzheimers Dis; 2018; 63(3):1075-1088. PubMed ID: 29710722
[TBL] [Abstract][Full Text] [Related]
27. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals.
Neroev VV; Archipova MM; Bakeeva LE; Fursova AZh; Grigorian EN; Grishanova AY; Iomdina EN; Ivashchenko ZhN; Katargina LA; Khoroshilova-Maslova IP; Kilina OV; Kolosova NG; Kopenkin EP; Korshunov SS; Kovaleva NA; Novikova YP; Philippov PP; Pilipenko DI; Robustova OV; Saprunova VB; Senin II; Skulachev MV; Sotnikova LF; Stefanova NA; Tikhomirova NK; Tsapenko IV; Shchipanova AI; Zinovkin RA; Skulachev VP
Biochemistry (Mosc); 2008 Dec; 73(12):1317-28. PubMed ID: 19120017
[TBL] [Abstract][Full Text] [Related]
28. Novel mitochondria-targeted antioxidants, "Skulachev-ion" derivatives, accelerate dermal wound healing in animals.
Demianenko IA; Vasilieva TV; Domnina LV; Dugina VB; Egorov MV; Ivanova OY; Ilinskaya OP; Pletjushkina OY; Popova EN; Sakharov IY; Fedorov AV; Chernyak BV
Biochemistry (Mosc); 2010 Mar; 75(3):274-80. PubMed ID: 20370605
[TBL] [Abstract][Full Text] [Related]
29. Mitochondria-targeted antioxidant SkQ1 reduces age-related alterations in the ultrastructure of the lacrimal gland.
Bakeeva LE; Eldarov CM; Vangely IM; Kolosova NG; Vays VB
Oncotarget; 2016 Dec; 7(49):80208-80222. PubMed ID: 27852065
[TBL] [Abstract][Full Text] [Related]
30. New Data on Effects of SkQ1 and SkQT1 on Rat Liver Mitochondria and Yeast Cells.
Rogov AG; Goleva TN; Trendeleva TA; Ovchenkova AP; Aliverdieva DA; Zvyagilskaya RA
Biochemistry (Mosc); 2018 May; 83(5):552-561. PubMed ID: 29738689
[TBL] [Abstract][Full Text] [Related]
31. Effect of SkQ1 eye drops on the rat lens metabolomic composition and the chaperone activity of α-crystallin.
Yanshole LV; Yanshole VV; Snytnikova OA; Fursova AZh; Kolosova NG; Tsentalovich YP; Sagdeev RZ
Dokl Biochem Biophys; 2015; 464():341-5. PubMed ID: 26518564
[TBL] [Abstract][Full Text] [Related]
32. SkQ1 treatment and food restriction--two ways to retard an aging program of organisms.
Skulachev VP
Aging (Albany NY); 2011 Nov; 3(11):1045-50. PubMed ID: 22170754
[TBL] [Abstract][Full Text] [Related]
33. New data on programmed aging - slow phenoptosis.
Skulachev MV; Skulachev VP
Biochemistry (Mosc); 2014 Oct; 79(10):977-93. PubMed ID: 25519058
[TBL] [Abstract][Full Text] [Related]
34. Changes in Glial Support of the Hippocampus during the Development of an Alzheimer's Disease-like Pathology and Their Correction by Mitochondria-Targeted Antioxidant SkQ1.
Rudnitskaya EA; Burnyasheva AO; Kozlova TA; Peunov DA; Kolosova NG; Stefanova NA
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163053
[TBL] [Abstract][Full Text] [Related]
35. SkQ1 slows development of age-dependent destructive processes in retina and vascular layer of eyes of wistar and OXYS rats.
Saprunova VB; Lelekova MA; Kolosova NG; Bakeeva LE
Biochemistry (Mosc); 2012 Jun; 77(6):648-58. PubMed ID: 22817465
[TBL] [Abstract][Full Text] [Related]
36. An antioxidant specifically targeting mitochondria delays progression of Alzheimer's disease-like pathology.
Stefanova NA; Muraleva NA; Maksimova KY; Rudnitskaya EA; Kiseleva E; Telegina DV; Kolosova NG
Aging (Albany NY); 2016 Oct; 8(11):2713-2733. PubMed ID: 27750209
[TBL] [Abstract][Full Text] [Related]
37. Single-Nucleotide Polymorphisms Associated with the Senescence-Accelerated Phenotype of OXYS Rats: A Focus on Alzheimer's Disease-Like and Age-Related-Macular-Degeneration-Like Pathologies.
Devyatkin VA; Redina OE; Kolosova NG; Muraleva NA
J Alzheimers Dis; 2020; 73(3):1167-1183. PubMed ID: 31929160
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective effects of ceftriaxone treatment on cognitive and neuronal deficits in a rat model of accelerated senescence.
Tikhonova MA; Ho SC; Akopyan AA; Kolosova NG; Weng JC; Meng WY; Lin CL; Amstislavskaya TG; Ho YJ
Behav Brain Res; 2017 Jul; 330():8-16. PubMed ID: 28487222
[TBL] [Abstract][Full Text] [Related]
39. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells.
Agapova LS; Chernyak BV; Domnina LV; Dugina VB; Efimenko AY; Fetisova EK; Ivanova OY; Kalinina NI; Khromova NV; Kopnin BP; Kopnin PB; Korotetskaya MV; Lichinitser MR; Lukashev AL; Pletjushkina OY; Popova EN; Skulachev MV; Shagieva GS; Stepanova EV; Titova EV; Tkachuk VA; Vasiliev JM; Skulachev VP
Biochemistry (Mosc); 2008 Dec; 73(12):1300-16. PubMed ID: 19120016
[TBL] [Abstract][Full Text] [Related]
40. Long-term antioxidant supplementation attenuates oxidative stress markers and cognitive deficits in senescent-accelerated OXYS rats.
Kolosova NG; Shcheglova TV; Sergeeva SV; Loskutova LV
Neurobiol Aging; 2006 Sep; 27(9):1289-97. PubMed ID: 16246464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
